j
goronzi
age
major
factor
determin
qualiti
quantiti
immun
respons
age
depend
appar
throughout
life
obviou
extrem
age
infant
older
adult
exhibit
blunt
immun
respons
infect
vaccin
howev
underli
mechan
immun
dysfunct
distinct
infant
born
limit
antigen
exposur
immatur
immun
system
howev
progress
develop
throughout
infanc
childhood
mechan
underli
immun
dysfunct
older
adult
broadli
term
immunosenesc
term
reminisc
cellular
senesc
defin
loss
abil
prolifer
result
irrevers
cell
cycl
block
howev
mislead
interpret
immun
age
accumul
senesc
cell
similar
age
gener
numer
pathway
involv
declin
immun
compet
linear
earli
age
year
vaccin
respons
select
vaccin
eg
hepat
b
start
declin
incid
rate
herp
zoster
reactiv
latent
varicellazost
viru
vzv
start
increas
age
year
morbid
mortal
influenza
infect
abrupt
transit
appear
occur
eighth
decad
life
term
public
health
infect
major
caus
morbid
young
old
although
child
mortal
rate
drop
almost
pathogen
infect
still
one
largest
caus
infant
mortal
worldwid
account
million
death
year
vaccin
help
chang
infecti
landscap
children
young
adult
certain
vaccin
streptococcu
pneumonia
still
limit
protect
capac
extrem
age
suscept
pathogen
infect
ineffect
vaccin
even
greater
older
adult
young
infant
moreov
age
function
immun
system
import
tissu
repair
increas
import
degen
diseas
vital
cancer
surveil
immunosenesc
increas
import
chang
popul
demograph
increas
number
individu
older
year
develop
develop
countri
infant
first
start
develop
immun
system
utero
maintain
fine
balanc
immunolog
toler
help
prevent
proinflammatori
respons
utero
abil
respond
foreign
antigen
exposur
upon
birth
immunosuppress
regulatori
pathway
util
fetu
protect
possibl
infect
maternalfet
reject
utero
still
reflect
newborn
infant
immun
system
character
immunesuppress
antiinflammatori
immatur
cellular
respons
foreign
antigen
although
newborn
young
infant
lack
abil
mount
effect
immun
respons
mani
pathogen
acquir
initi
immun
protect
passiv
transfer
matern
immunoglobulin
g
igg
utero
via
placenta
term
passiv
immun
secretori
iga
antimicrobi
factor
present
matern
breast
milk
altern
passiv
immun
eg
preterm
birth
lead
increas
suscept
infect
breakdown
immun
toler
infant
passiv
immun
enhanc
vaccin
pregnant
mother
promot
transfer
vaccinespecif
igg
utero
howev
within
first
month
life
matern
igg
wane
breastfeed
discontinu
infant
must
activ
develop
innat
adapt
immun
respons
initi
maintain
immun
protect
overview
develop
innat
adapt
cell
well
repertoir
divers
age
outlin
fig
innat
immun
system
typic
consid
first
line
defens
infect
develop
innat
immun
system
begin
utero
classic
innat
cell
type
present
end
first
trimest
monocyt
dendrit
cell
dc
earliest
cell
observ
week
gestat
wg
follow
granulocyt
natur
killer
nk
cell
wg
innat
immun
cell
expand
number
matur
gestat
howev
birth
function
innat
immun
cell
still
diminish
significantli
compar
later
life
earli
infanc
cell
type
innat
immun
system
demonstr
impair
function
rang
reduc
mobil
skew
cytokin
product
respons
innat
immun
stimul
signific
function
limit
neonat
innat
immun
cell
collect
inabl
kill
pathogen
limit
chemotaxi
neutrophil
accompani
reduc
abil
effect
kill
pathogen
result
poor
phagocytosi
decreas
secret
neutrophil
extracellular
trap
inflammatori
condit
combin
result
decreas
kill
infecti
pathogen
moreov
nk
cell
plasmacytoid
dc
reduc
capac
prevent
although
lymphocyt
initi
develop
within
fetal
liver
wg
bone
marrow
wg
tcell
matur
occur
thymu
b
cell
continu
matur
bone
marrow
utero
birth
cours
gestat
tcell
bcell
compart
expand
reach
absolut
cell
concentr
greater
adult
birth
thu
defect
cellular
gener
account
immun
limit
observ
infant
howev
composit
lymphocyt
popul
within
young
infant
distinct
adult
birth
newborn
infant
tand
bcell
compart
consist
mainli
immatur
cell
recent
migrat
thymu
bone
marrow
popul
infant
tand
bcell
repertoir
less
divers
within
receptor
antigenbind
region
compar
adult
tcell
receptor
display
reduc
vj
complex
fewer
amino
acid
addit
addit
b
cell
decreas
bcell
receptor
divers
less
affin
matur
ie
somat
hypermut
chapter
compar
adult
popul
increas
level
recent
thymic
emigr
cell
maintain
peripheri
tissu
earli
infanc
effector
memori
cell
found
select
lung
gastrointestin
gi
tract
young
infant
like
mucos
tissu
earliest
site
antigen
exposur
classswitch
antibodi
produc
b
cell
requir
mucos
protect
primarili
iga
system
protect
infect
reduc
cytotox
function
lower
secret
interferon
respect
addit
antigenpres
cell
apc
unabl
provid
effect
help
cell
reduc
express
costimulatori
molecul
skew
cytokin
product
toward
antiinflammatori
thelper
induc
cytokin
combin
limit
earli
infanc
lead
increas
suscept
viral
bacteri
infect
also
contribut
reduc
function
adapt
immun
cell
reduc
antibacteri
respons
ie
phagocytosi
secret
neutrophil
extracellular
trap
net
neutrophil
monocyt
impair
neutrophil
chemokinesi
direct
movement
reduc
antibodi
titer
observ
infanc
account
function
inabl
infant
b
cell
undergo
classswitch
igm
iga
igg
upon
antigen
stimul
poor
surviv
antibodysecret
plasma
cell
within
infant
bone
marrow
moreov
infant
b
cell
lower
rate
somat
hypermut
compar
adult
import
affin
matur
gener
highaffin
antibodi
although
defect
partial
attribut
extrins
tcell
defect
poor
tfh
gener
intrins
defect
infant
b
cell
eg
lack
costimulatori
molecul
receptor
cellindepend
factor
also
prevent
effect
antibodi
respons
collect
neonat
bcell
defect
lead
less
effect
shorterliv
antibodi
respons
infecti
pathogen
vaccin
earli
infanc
primarili
igg
opson
neutral
antibodydepend
cellular
cytotox
adcc
howev
infant
demonstr
significantli
lower
level
igg
iga
compar
adult
throughout
first
year
life
peripheri
mucosa
acquisit
matur
adapt
immun
system
requir
exposur
antigen
cell
form
immunolog
memori
infant
born
limit
antigen
exposur
thu
littl
memori
infant
respons
antigen
stimul
tand
bcell
compart
display
alter
function
compar
adult
strike
alter
seen
within
tcell
compart
character
significantli
increas
frequenc
immunosuppress
regulatori
cell
treg
infant
vs
adult
chang
accompani
increas
subset
defect
differenti
effector
tfollicular
helper
tfh
cell
earli
infanc
moreov
decreas
express
lck
infant
cell
lead
decreas
tcell
activ
upon
antigen
exposur
alter
differenti
th
subset
blunt
tcell
activ
promot
toleranceinduc
environ
good
control
unnecessari
respons
foreign
antigen
exposur
birth
howev
also
lead
inhibit
effect
cytotox
cell
limit
bcell
antibodi
respons
infecti
pathogen
vaccin
fig
neutrophil
short
halflif
bodi
need
produc
cellskg
per
day
addit
lymphocyt
longliv
also
numer
wider
tissu
distribut
daili
need
order
sever
billion
cell
studi
show
hematopoiet
tissu
bone
marrow
decreas
age
similar
declin
seen
frequenc
peripher
hematopoiet
stem
cell
hsc
addit
numer
differ
function
potenti
hsc
chang
age
old
hsc
exhibit
reduc
capac
regener
hematopoiet
system
telomeras
express
peripher
hsc
fulli
protect
shorten
telomer
length
seen
age
similar
differenti
mononuclear
cell
lymphoid
differenti
potenti
diminish
age
favor
myeloid
differenti
result
alter
lineag
specif
program
driven
dna
damag
epigenet
chang
shift
may
contribut
clinic
observ
hscderiv
leukemia
preferenti
lymphoid
phenotyp
young
myeloid
one
older
adult
one
first
environment
exposur
infant
experi
colon
bacteria
within
hour
birth
infant
intestin
tract
colon
nonpathogen
bacteria
term
microbiom
chapter
microbiom
reach
concentr
bacteria
per
gram
stool
age
day
mirror
adultlik
composit
age
year
earli
studi
anim
model
demonstr
microbi
colon
essenti
normal
develop
immun
system
earli
infanc
throughout
life
particular
iga
abund
antibodi
within
gi
tract
requir
presenc
colon
bacteri
develop
longterm
mainten
moreov
specif
composit
microbiom
influenc
gener
innat
lymphoid
cell
tcell
subset
eg
treg
tfh
antibodi
develop
perturb
infant
microbiom
caus
factor
mode
deliveri
antibiot
treatment
diet
may
significantli
alter
develop
immun
respons
describ
babi
deliv
via
csection
microbiom
composit
distinct
vagin
deliv
babi
latter
domin
skin
bacteria
eg
staphylococcu
instead
vagin
bacteria
eg
lactobacillu
prevotella
differ
correl
increas
incid
allergi
asthma
childhood
suggest
causal
link
microbiom
suscept
allergi
find
preliminari
evid
need
support
notion
microbiom
influenc
develop
infant
immun
system
newborn
young
infant
highli
suscept
pathogen
infect
first
month
year
life
inde
infect
one
major
caus
mortal
account
global
infant
mortal
million
death
per
year
caus
respiratori
tract
infect
eg
streptococcu
pneumonia
haemophilu
influenza
type
b
respiratori
syncyti
viru
rsv
almost
amount
intestin
infect
eg
rotaviru
escherichia
coli
develop
distribut
vaccin
target
pathogen
significantli
reduc
infant
infect
rate
subsequ
mortal
howev
vaccin
efficaci
vari
depend
infant
gestat
age
birth
mode
vaccin
deliveri
oral
vs
intramuscular
interfer
matern
antibodi
acquir
passiv
immun
via
breast
milk
immatur
infant
immun
respons
describ
addit
infant
requir
multipl
vaccin
booster
elicit
maintain
robust
protect
immun
infecti
pathogen
chapter
better
understand
limit
human
infant
immun
system
prevent
effect
immun
respons
particularli
mucos
site
pathogen
initi
infect
would
facilit
gener
better
vaccin
design
overcom
limit
induc
rapid
robust
immun
protect
earli
infanc
immun
system
constant
demand
cellular
replenish
compens
peripher
loss
cell
death
age
influenc
immun
cell
gener
popul
homeostasi
hematopoiet
stem
cell
hsc
reduc
frequenc
bias
toward
myeloid
lineag
lymphoid
lineag
myeloid
cell
gener
larg
intact
bcell
gener
declin
bcell
repertoir
select
disturb
result
thymic
involut
cell
gener
homeostat
prolifer
peripher
cell
abil
rebuild
tcell
repertoir
lymphocytedeplet
intervent
sever
compromis
midadulthood
virusspecif
effector
tcell
popul
accumul
consequ
lymphocyt
replenish
affect
age
myeloid
lineag
peripher
neutrophil
number
declin
abl
recov
therapyinduc
deplet
eg
chemotherapi
furthermor
loss
abil
gener
robust
neutrophilia
respons
infect
stressor
addit
hscintrins
alter
lineag
commit
defect
bloodborn
factor
bone
marrow
nich
contribut
declin
bcell
gener
consequ
recoveri
bcell
deplet
eg
treatment
antibodi
treat
bcell
malign
autoimmun
diseas
increas
morbid
mortal
bacteri
infect
eg
pneumococci
increas
morbid
mortal
viral
infect
eg
influenza
viru
respiratori
syncyti
viru
rsv
ineffect
primari
vaccin
multipl
booster
requir
vaccin
elicit
effect
protect
suscept
allergi
asthma
microbiom
colon
disrupt
earli
infanc
vzvspecif
memori
cell
postul
explain
lack
viral
control
mechan
contrast
ebv
cmv
infect
relaps
sever
immunocompromis
individu
normal
immun
age
immun
system
commit
extraordinari
resourc
control
cmv
cmvspecif
cell
make
larg
fraction
entir
tcell
repertoir
whether
memori
inflat
broader
implic
immun
health
remain
matter
controversi
expans
cmvspecif
cell
may
compromis
size
central
memori
cell
repertoir
howev
mani
cmvspecif
cell
phenotyp
enddifferenti
effector
cell
lack
express
therefor
compet
space
cell
enddifferenti
cell
express
neg
regulatori
receptor
killer
lectinlik
receptor
klr
killer
immunoglobulinlik
receptor
kir
immunoglobulinlik
transcript
ilt
famili
appear
constrain
otherwis
unoppos
expans
spite
inhibitori
receptor
cell
compet
effector
cell
capabl
produc
inflammatori
cytokin
therefor
possibl
contribut
inflamm
older
adult
enddifferenti
effector
cell
distinguish
exhaust
cell
tcell
exhaust
seen
chronic
stimul
highli
replic
virus
tumor
cell
character
express
inhibitori
receptor
program
death
tcell
immunoglobulin
mucindomain
lymphocyt
activ
gene
tcell
exhaust
gener
featur
per
se
tcell
age
age
host
environ
character
continu
presenc
inflammatori
mediat
independ
acut
chronic
diseas
fig
even
healthi
older
adult
tumor
necrosi
factor
tnf
serum
level
twofold
fourfold
higher
young
adult
lowlevel
system
inflamm
play
import
role
progress
sever
agerel
diseas
includ
alzheim
diseas
atherosclerosi
cancer
moreov
inflammatori
marker
associ
sever
condit
characterist
older
adult
serum
concentr
correl
loss
mobil
advent
disabl
increas
mortal
older
individu
shown
among
higher
level
increas
crossreact
protein
crp
serum
level
increas
white
blood
cell
wbc
count
presum
result
increas
product
neutrophil
predispos
associ
frailti
caus
relationship
may
also
exist
increas
product
ageassoci
loss
muscl
mass
eventu
present
sarcopenia
longliv
individu
centenarian
tend
lower
level
proinflammatori
cytokin
increas
level
antiinflammatori
mediat
cortison
support
concept
lowlevel
inflamm
detriment
healthi
age
product
inflammatori
cytokin
driven
sever
mechan
failur
adapt
immun
system
lead
less
effect
control
chronic
viral
infect
well
incomplet
respons
exogen
challeng
result
increas
prolong
innat
immun
activ
defect
epitheli
barrier
function
well
declin
mucosaassoci
incomplet
delay
older
adult
moreov
frequenc
typic
memori
b
cell
express
declin
wherea
bcell
subpopul
increas
particular
function
distinct
bcell
popul
respond
tolllik
receptor
tlr
stimul
describ
ageassoci
differ
bcell
select
expans
may
contribut
monoclon
gammopathi
individu
older
year
chapter
increas
autoantibodi
increas
age
highthroughput
sequenc
ig
gene
promis
provid
insight
ageassoci
declin
bcell
respons
singlecel
level
data
far
indic
older
individu
prevaccinationexpand
bcell
popul
high
mutat
load
expand
vaccin
suggest
bcell
respons
older
individu
reli
adapt
restrict
repertoir
memori
sequenc
tcell
gener
affect
age
myeloid
lymphoid
lineag
involut
thymu
thymu
undergo
dramat
structur
chang
begin
childhood
puberti
thymopoiet
nich
disappear
number
thymic
epitheli
cell
thymocyt
declin
parallel
thymic
perivascular
space
increas
one
major
structur
chang
appear
compensatori
respons
rather
activ
regul
development
step
thymic
organ
transform
accumul
infiltr
adipocyt
perivascular
space
thymic
resect
children
undergo
cardiac
surgeri
reproduc
mani
tcell
repertoir
chang
individu
usual
seen
confirm
thymic
product
growth
period
childhood
adolesc
import
howev
throughout
adulthood
homeostat
prolifer
cell
account
bulk
tcell
gener
human
cell
process
robust
frequenc
cell
moder
declin
age
contrast
tcell
compart
clearli
shrink
howev
repertoir
divers
ie
number
differ
tcell
receptor
tcr
remain
high
tcell
subset
suggest
thymic
activ
necessari
prevent
hole
repertoir
repertoir
form
strategi
reactiv
thymic
tcell
gener
import
older
patient
restor
tcell
repertoir
medic
intervent
chemotherapi
bone
marrow
transplant
compar
healthi
counterpart
adapt
system
respond
antigen
challeng
clonal
expans
differenti
effector
cell
follow
clonal
downsiz
persist
longliv
memori
cell
infect
therefor
leav
perman
imprint
immun
system
mechan
vaccin
capit
howev
pathogeninduc
clonal
expans
also
repres
challeng
homeostat
mechan
suppos
maintain
balanc
among
memori
effector
cell
particularli
evid
persist
infect
offend
pathogen
clear
herp
viru
infect
highli
preval
appar
healthi
popul
without
caus
activ
diseas
establish
latenc
classic
exampl
varicellazost
viru
vzv
epsteinbarr
viru
ebv
cytomegaloviru
cmv
effect
herp
virus
immun
age
differ
greatli
vzv
tend
relaps
age
reactiv
present
shingl
decreas
frequenc
signal
pathway
low
respons
cytokin
stimuli
frequent
seen
cell
increas
baselin
activ
signal
pathway
eg
cell
constitut
increas
signal
transduc
activ
transcript
phosphoryl
respond
less
macrophagecolonystimul
factor
gmcsf
type
iii
ifn
cytokin
activ
stat
attenu
signal
pathway
induct
neg
feedback
loop
explain
part
reduc
respons
function
cell
innat
immun
system
although
neutrophil
monocytemacrophag
number
remain
normal
mani
function
declin
age
decreas
chemotaxi
neutrophil
delay
tissu
infiltr
reduc
phagocytosi
respiratori
burst
compromis
abil
control
bacteri
infect
tlrinduc
monocyt
macrophag
activ
dampen
older
adult
declin
respons
exampl
tlr
stimul
partli
revers
vitro
suggest
intrins
adapt
immun
cell
also
directli
affect
proinflammatori
environ
age
host
equal
import
cellintrins
chang
appear
consequ
replic
histori
failur
cellular
process
dna
repair
autophagi
program
obvious
influenc
age
cellular
senesc
hematopoiet
cell
lineag
includ
stem
cell
telomer
length
declin
age
particular
import
cell
much
respons
depend
abil
prolifer
clonal
expand
telomer
eros
result
cumul
replic
histori
dna
damag
also
declin
abil
express
telomeras
repair
telomer
end
lymphocyt
older
adult
differenti
young
although
obviou
cell
increas
differenti
also
note
b
cell
cell
fig
differenti
gener
driven
antigen
recognit
could
also
occur
absenc
exogen
antigen
influenc
cytokin
prolifer
alon
may
suffici
drive
initi
step
differenti
classic
lymphoreticular
tissu
malt
result
increas
leakag
increas
system
level
lipopolysaccharid
lp
innat
immun
activ
failur
maintain
tcell
popul
homeostasi
accumul
effector
cell
also
favor
inflammatori
respons
inflamm
older
adult
schemat
diagram
depict
possibl
mechan
account
increas
product
inflammatori
mediat
age
mediat
contribut
mani
ageassoci
diseas
activ
innat
immun
system
result
defect
epitheli
barrier
function
activ
innat
immun
system
result
defect
adapt
immun
accumul
adipocyt
produc
inflammatori
mediat
accumul
activ
teffector
cell
popul
dna
damageinduc
transcript
inflammatori
cytokin
gene
senesc
cell
immun
system
howev
sourc
inflammatori
cytokin
adipocyt
part
replac
muscl
cell
older
adult
produc
variou
inflammatori
mediat
cellular
senesc
also
associ
product
cytokin
persist
dna
damag
respons
signal
induc
irrevers
cell
cycl
block
characterist
cellular
senesc
also
initi
transcript
program
secret
numer
growth
factor
proteas
inflammatori
cytokin
term
senescenceassoci
secretori
phenotyp
sasp
describ
far
immun
age
occur
system
level
organiz
restructur
equal
import
chang
singlecel
level
partli
cellintrins
partli
caus
host
environ
increas
cytokin
concentr
older
adult
activ
also
attenu
activ
cell
chang
cell
surfac
molecul
seen
termin
differenti
gain
loss
express
strike
function
import
predominantli
cell
gain
express
cell
surfac
receptor
usual
found
nk
cell
receptor
inhibitori
function
also
stimul
sinc
express
receptor
individu
cell
stochast
consequ
rang
immunosuppress
autoreact
profound
note
consequ
human
senesc
increas
suscept
infect
upper
respiratori
bacteri
urinari
tract
infect
frequent
older
popul
less
contain
innat
immun
system
preexist
adapt
immun
surprisingli
immun
system
older
adult
abl
induc
protect
respons
new
antigen
individu
expos
past
clinic
import
exampl
sever
acut
respiratori
syndrom
sar
epidem
west
nile
fever
viru
infect
firsttim
vaccin
live
virus
exampl
yellow
fever
viru
associ
increas
morbid
even
mortal
older
adult
despit
annual
vaccin
influenza
infect
continu
associ
high
morbid
mortal
pneumonia
caus
rsv
usual
exampl
acquisit
memorylik
effector
phenotyp
lymphopeniainduc
homeostat
prolifer
socal
virtual
memori
cell
presum
never
seen
exogen
antigen
identifi
mous
model
clonal
expans
also
seen
within
human
tcell
compart
chang
gene
express
seen
cell
age
may
repres
partial
differenti
declin
microrna
chang
express
phosphatas
signal
molecul
increas
express
cytoplasm
phosphatas
impair
tcrinduc
exposur
age
host
environ
eg
inflammatori
cytokin
activ
neg
regulatori
signal
loop
telomer
eros
impair
prolif
compet
restraint
clonal
expans
enddifferenti
reduc
function
plastic
activ
specif
gene
program
modifi
cell
function
gene
program
associ
differenti
eg
microrna
mirna
gene
program
associ
tcell
exhaust
eg
express
program
death
includ
antigenreceptor
specif
respond
vaccin
repertoir
contract
result
thymic
involut
memori
inflat
appear
less
sever
origin
thought
current
explor
intervent
restor
thymic
activ
may
meaning
select
popul
bone
marrow
recipi
defici
antigenpres
system
costimulatori
signal
may
overcom
identifi
new
adjuv
increas
vaccin
dose
anoth
promis
approach
live
vaccin
selfrepl
construct
also
accomplish
higher
antigen
load
may
suffici
safeti
profil
older
adult
direct
target
signal
defect
older
cell
result
increas
express
cytoplasm
phosphatas
inhibitori
cell
surfac
receptor
feasibl
shown
checkpoint
inhibitor
oncolog
howev
approach
need
demonstr
much
better
safeti
profil
intervent
influenc
inflamm
older
adult
present
need
nonspecif
given
multitud
underli
mechan
immunomodulatori
therapi
obvious
standard
practic
patient
autoimmun
diseas
exhibit
acceler
age
increas
allcaus
mortal
calori
restrict
slow
immun
age
extent
effect
gener
well
accept
statin
aspirin
routin
use
prevent
cardiovascular
diseas
effect
may
mostli
antiinflammatori
futur
intervent
requir
develop
mild
lowtox
medic
reduc
lowgrad
inflamm
impair
abil
prevent
innat
immun
activ
respons
harm
antigen
infect
young
children
uncommon
immun
compet
chronic
infect
also
compromis
age
best
exampl
reactiv
vzv
manifest
shingl
increas
morbid
mortal
bacteri
infect
eg
pneumococci
increas
morbid
mortal
viral
infect
eg
influenza
west
nile
fever
reactiv
latent
viru
eg
varicella
zoster
viru
ineffect
primari
booster
vaccin
acceler
degen
diseas
result
product
inflammatori
mediat
eg
atherosclerot
diseas
alzheim
diseas
osteoarthr
increas
incid
autoimmun
diseas
eg
polymyalgia
rheumatica
giant
cell
arter
rheumatoid
arthriti
vaccin
pneumococc
antigen
influenza
strain
vzv
recommend
older
adult
howev
efficaci
vaccin
reduc
immun
age
also
predispos
autoimmun
manifest
breakdown
selftoler
autoantibodi
common
find
healthi
older
adult
mani
autoantibodi
specif
common
autoantigen
igg
fc
nuclear
compon
risk
sever
autoimmun
diseas
notabl
polymyalgia
rheumatica
giant
cell
arter
increas
age
although
polymyalgia
rheumatica
predominantli
present
activ
innat
immun
giant
cell
arter
clearli
diseas
adapt
immun
system
celldepend
granulomat
inflamm
vascular
wall
midsiz
larg
arteri
lowgrad
inflamm
age
host
direct
clinic
consequ
promot
frailti
sarcopenia
acceler
degen
diseas
includ
coronari
arteri
diseas
osteopenia
alzheim
diseas
acceler
immun
age
may
one
reason
autoimmun
diseas
rheumatoid
arthriti
ra
associ
shorter
life
span
increas
risk
cardiovascular
morbid
inflamm
manifest
acceler
age
also
implic
increas
morbid
mortal
patient
hiv
infect
spite
highli
activ
antiretrovir
therapi
haart
vaccin
hold
promis
reduc
increas
suscept
infect
young
children
older
adult
improv
vaccin
respons
proven
challeng
current
strategi
target
elus
pediatr
pathogen
eg
rsv
includ
matern
vaccin
ie
mother
vaccin
pregnanc
vaccinespecif
igg
transfer
utero
infant
develop
infantspecif
vaccin
adjuv
util
newer
understand
develop
infant
immun
system
also
investig
role
microbiom
immun
develop
dysfunct
may
open
new
strategi
influenc
immun
system
develop
reduc
immun
defici
prevent
inappropri
hyperact
older
adult
proper
tcell
respons
infecti
organ
vaccin
depend
avail
tcell
repertoir
improv
vaccin
strategi
tailor
infant
age
immun
system
novel
adjuv
novel
vaccin
deliveri
system
new
vaccin
pregnant
femal
confer
passiv
immun
manipul
microbiom
composit
influenc
immun
system
develop
thymic
rejuven
eg
kgf
mediat
prevent
chronic
infect
acceler
immun
age
eg
immun
cmv
pharmacolog
approach
improv
b
cell
activ
clonal
expans
differenti
treatment
inflammag
